Literature DB >> 12717374

Cholangiocarcinoma: current concepts and insights.

Gregory J Gores1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12717374     DOI： 10.1053/jhep.2003.50200

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  84 in total

1.  Cholangiocarcinoma.

Authors:  Prabhleen Chahal; Todd H Baron
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

2.  Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.

Authors:  Arndt Vogel; Joseph E Aslan; Holger Willenbring; Christian Klein; Milton Finegold; Howard Mount; Gary Thomas; Markus Grompe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

Review 3.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

4.  Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.

Authors:  Indsey Kennedy; Heather Francis; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Liver Res       Date:  2017-04-26

5.  Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.

Authors:  Holger G Hass; Oliver Nehls; Juergen Jobst; Andrea Frilling; Ulrich Vogel; Stephan Kaiser
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

6.  Progranulin: a novel regulator of gastrointestinal cancer progression.

Authors:  Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2013-07

7.  Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Authors:  Tetsuya Shimizu; Shigeki Yokomuro; Yoshiaki Mizuguchi; Yutaka Kawahigashi; Yasuo Arima; Nobuhiko Taniai; Yasuhiro Mamada; Hiroshi Yoshida; Koho Akimaru; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.

Authors:  Xin-Da Zhou; Zhao-You Tang; Jia Fan; Jian Zhou; Zhi-Quan Wu; Lun-Xiu Qin; Zeng-Chen Ma; Hui-Chuan Sun; Shuang-Jian Qiu; Yao Yu; Ning Ren; Qing-Hai Ye; Lu Wang; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

9.  Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.

Authors:  Giammarco Fava; Sharon Demorrow; Eugenio Gaudio; Antonio Franchitto; Paolo Onori; Guido Carpino; Shannon Glaser; Heather Francis; Monique Coufal; Luca Marucci; Domenico Alvaro; Marco Marzioni; Trenton Horst; Romina Mancinelli; Antonio Benedetti; Gianfranco Alpini
Journal:  Liver Int       Date:  2009-03-09       Impact factor: 5.828

10.  Current status of photodynamic therapy for bile duct cancer.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim
Journal:  Clin Endosc       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.